Literature DB >> 15845756

Maintenance treatment outcomes in older patients with bipolar I disorder.

Martha Sajatovic1, Laszlo Gyulai, Joseph R Calabrese, Thomas R Thompson, Barbara G Wilson, Robin White, Gary Evoniuk.   

Abstract

OBJECTIVE: The efficacy and tolerability of mood stabilizers in older adults with bipolar disorder remains understudied. Authors retrospectively examined response to lamotrigine, lithium, and placebo in older (>or=age 55) adults with Bipolar I disorder (DSM-IV) who participated in two mixed-age, maintenance studies examining time to intervention for an emerging mood episode (manic/hypomanic/mixed or depressed) and drug tolerability.
METHODS: In all, 588 patients received double-blind lamotrigine (LTG, 100 mg-400 mg/day), lithium (Li, 0.8 mEq/L-1.1 mEq/L), or placebo (PBO); data from 98 older adults (LTG: 33, Li: 34, PBO: 31) were examined. Mean modal total daily doses were LTG 240 mg and Li 750 mg.
RESULTS: LTG significantly delayed time to intervention for any mood episode and for a depressive episode, compared with placebo. Li significantly delayed time to intervention for mania/hypomania/mixed compared with placebo. Back pain and headache were the most common adverse events during LTG treatment; rash: LTG, 3%; Li, 6%; and PBO, 0; no serious rash was reported. The most common adverse events (>10%) during lithium treatment were dyspraxia, tremor, xerostomia, headache, infection, amnesia, dizziness, diarrhea, nausea, and fatigue.
CONCLUSION: Lamotrigine and lithium may be effective and well-tolerated maintenance therapies for older adults with Bipolar I depression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845756     DOI: 10.1176/appi.ajgp.13.4.305

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  13 in total

1.  Enhancing medication adherence: in older adults with bipolar disorder.

Authors:  Colin A Depp; Barry D Lebowitz
Journal:  Psychiatry (Edgmont)       Date:  2007-06

2.  Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report.

Authors:  Martha Sajatovic; Ariel Gildengers; Rayan K Al Jurdi; Laszlo Gyulai; Kristin A Cassidy; Rebecca L Greenberg; Martha L Bruce; Benoit H Mulsant; Thomas Ten Have; Robert C Young
Journal:  Bipolar Disord       Date:  2011-05       Impact factor: 6.744

3.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

4.  Lithium for older adults with bipolar disorder: Should it still be considered a first-line agent?

Authors:  Kenneth I Shulman
Journal:  Drugs Aging       Date:  2010-08-01       Impact factor: 3.923

Review 5.  Using Lithium in Older Age Bipolar Disorder: Special Considerations.

Authors:  Jocelyn Fotso Soh; Sivan Klil-Drori; Soham Rej
Journal:  Drugs Aging       Date:  2019-02       Impact factor: 3.923

6.  Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder.

Authors:  Sachin Bhalerao; Lisa S Seyfried; Hyungjin Myra Kim; Claire Chiang; Janet Kavanagh; Helen C Kales
Journal:  J Geriatr Psychiatry Neurol       Date:  2012-03       Impact factor: 2.680

Review 7.  A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force.

Authors:  Martha Sajatovic; Sergio A Strejilevich; Ariel G Gildengers; Annemiek Dols; Rayan K Al Jurdi; Brent P Forester; Lars Vedel Kessing; John Beyer; Facundo Manes; Soham Rej; Adriane R Rosa; Sigfried Ntm Schouws; Shang-Ying Tsai; Robert C Young; Kenneth I Shulman
Journal:  Bipolar Disord       Date:  2015-09-19       Impact factor: 6.744

8.  Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study.

Authors:  Brent P Forester; Chris C Streeter; Yosef A Berlow; Hua Tian; Megan Wardrop; Chelsea T Finn; David Harper; Perry F Renshaw; Constance M Moore
Journal:  Am J Geriatr Psychiatry       Date:  2009-01       Impact factor: 4.105

Review 9.  Mood disorders in the elderly: prevalence, functional impact, and management challenges.

Authors:  Leandro da Costa Lane Valiengo; Florindo Stella; Orestes Vicente Forlenza
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-24       Impact factor: 2.570

Review 10.  Evaluation and treatment of older-age bipolar disorder: a narrative review.

Authors:  Rajesh R Tampi; Pallavi Joshi; Gargi Bhattacharya; Sheila Gupta
Journal:  Drugs Context       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.